Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Depreciation & Amortization (CF) (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Depreciation & Amortization (CF) for 4 consecutive years, with $74.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 13.85% year-over-year to $74.0 million, compared with a TTM value of $287.0 million through Dec 2025, up 7.09%, and an annual FY2025 reading of $287.0 million, up 7.09% over the prior year.
  • Depreciation & Amortization (CF) was $74.0 million for Q4 2025 at GE HealthCare Technologies, down from $75.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $75.0 million in Q3 2025 and bottomed at $56.0 million in Q1 2022.
  • Average Depreciation & Amortization (CF) over 4 years is $64.4 million, with a median of $64.5 million recorded in 2023.
  • Peak annual rise in Depreciation & Amortization (CF) hit 13.85% in 2025, while the deepest fall reached 2.94% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $59.0 million in 2022, then grew by 1.69% to $60.0 million in 2023, then increased by 8.33% to $65.0 million in 2024, then rose by 13.85% to $74.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for GEHC at $74.0 million in Q4 2025, $75.0 million in Q3 2025, and $72.0 million in Q2 2025.